Jeet Mukherjee

Jeet Mukherjee, Ph.D., is a seasoned professional in biotechnology equity research, currently serving as Vice President at BTIG since June 2023, focusing on oncology and cell therapy. Previously, Jeet held the position of Senior Research Associate at Casdin Capital, LLC from May 2021 to March 2023, and also worked as a Senior Associate and Biotechnology Equity Research Associate at Jefferies from June 2018 to May 2021, collaborating with senior analyst Biren Amin on equity research reports for 30 SMID cap biotechnology firms. Jeet's academic background includes a Ph.D. in Pharmacology from Weill Cornell Graduate School of Medical Sciences, where research concentrated on stem cell treatments for diabetes under Dr. Shuibing Chen, and a Bachelor of Science in Cell/Cellular and Molecular Biology from the University of Delaware. Additional early research experience includes work with Howard Hughes Medical Institute and the National Science Foundation, focusing on nanoparticle technology.